Pharma BD Deal Intelligence

Allergan, Inc. / SkinMedica, Inc.

2012 · Acquisition/Merger · $375M · Complete

Announcement Sentiment

Strongly positive

Allergan acquired SkinMedica for $350M upfront plus up to $25M sales-based contingent. Complemented existing Botox/Juvederm aesthetics franchise with leadership in physician-dispensed topical aesthetics skincare. Excluded Colorescience makeup line.

Did it work? Outcome assessment

Strategic verdict

Achieved Stated Rationale

Financial impact

Accretive

Pipeline outcome

Assets Advanced

Assessment window: 10yr post-close.

Key facts

Announced Nov 12, 2012
Closed Dec 19, 2012
Deal value $375M
Deal type Acquisition/Merger
Therapeutic area Aesthetic dermatology / cosmeceuticals
Indications Aesthetic dermatology / cosmeceuticals
Key assets Physician-dispensed topical aesthetic skincare (TNS Recovery Complex etc.)
Mechanism Multiple (topical, growth factor formulations)

See the full interactive analysis, sources & comparables →

← Browse all deals · How we score deals